» Articles » PMID: 39120336

RNAseq of Gingival Fibroblasts Exposed to PRF Membrane Lysates and PRF Serum

Overview
Journal Cells
Publisher MDPI
Date 2024 Aug 9
PMID 39120336
Authors
Affiliations
Soon will be listed here.
Abstract

Platelet-rich fibrin (PRF) is prepared by spontaneous coagulation of fractionated blood. When squeezed between two plates, PRF is separated into solid PRF membranes and a liquid exudate, the PRF serum. The question arises regarding how much the overall activity remains in the PRF membranes and what is discarded into the PRF serum. To this end, we have exposed gingival fibroblasts to lysates prepared from PRF membranes and PRF serum, followed by bulk RNA sequencing. A total of 268 up- and 136 down-regulated genes in gingival fibroblasts exposed to PRF membrane lysates were significantly regulated under the premise of a minimum log2 with 2.5-fold change and a minus log10 significance level of two, respectively. PRF serum only caused 62 up- and 32 down-regulated genes under these conditions. Among the 46 commonly up-regulated genes were CXCL1, CXCL5, CXCL6, CXCL8, IL33, IL6, and PTGS2/COX2, stanniocalcin-1-all linked to an inflammatory response. PRF membrane lysates further increased chemokines CCL2, CCL7, CXCL2, CXCL3, and IL1R1, IL1RL1, and IL1RN, as well as the paracrine factors IL11, LIF, IGF1, BMP2, BMP6, FGF2, and CCN2/CTGF, and all hyaluronan synthases. On the other hand, PRF serum increased DKK1. The genes commonly down-regulated by PRF membrane lysates and PRF serum included interferon-induced protein with tetratricopeptide repeats (IFIT1, IFIT2, IFIT3) and odd-skipped-related transcription factors (OSR1 and OSR2), as well as FGF18 and GDF15, respectively. Taken together, PRF membrane lysates, compared to PRF serum, cause a more complex response in gingival fibroblasts, but each increased chemokine expression in gingival fibroblasts.

Citing Articles

RNA Sequencing Revealed a Weak Response of Gingival Fibroblasts Exposed to Hyaluronic Acid.

Panahipour L, Imani A, Dos Santos Sanches N, Kuhtreiber H, Mildner M, Gruber R Bioengineering (Basel). 2025; 11(12.

PMID: 39768125 PMC: 11726844. DOI: 10.3390/bioengineering11121307.

References
1.
Wetzler M, Talpaz M, Lowe D, Baiocchi G, Gutterman J, Kurzrock R . Constitutive expression of leukemia inhibitory factor RNA by human bone marrow stromal cells and modulation by IL-1, TNF-alpha, and TGF-beta. Exp Hematol. 1991; 19(5):347-51. View

2.
Heberle H, Meirelles G, da Silva F, Telles G, Minghim R . InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams. BMC Bioinformatics. 2015; 16:169. PMC: 4455604. DOI: 10.1186/s12859-015-0611-3. View

3.
Miron R, Moraschini V, Fujioka-Kobayashi M, Zhang Y, Kawase T, Cosgarea R . Use of platelet-rich fibrin for the treatment of periodontal intrabony defects: a systematic review and meta-analysis. Clin Oral Investig. 2021; 25(5):2461-2478. PMC: 8060184. DOI: 10.1007/s00784-021-03825-8. View

4.
de Witt S, Verdoold R, Cosemans J, Heemskerk J . Insights into platelet-based control of coagulation. Thromb Res. 2014; 133 Suppl 2:S139-48. DOI: 10.1016/S0049-3848(14)50024-2. View

5.
Koenen R . The prowess of platelets in immunity and inflammation. Thromb Haemost. 2016; 116(4):605-12. DOI: 10.1160/TH16-04-0300. View